Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study

作者：Qiaoxuan Wang, Binyi Xiao, Yong Cheng, Aiwen Wu, Tao Zhang, Hui Wang, Xuan Zhang, Weixin Huang, Jinghua Tang, Jiang Wu, Scott R. Steele, Smitha Krishnamurthi, Yuan Li, Jian Cai, Ling-Heng Kong, Dandan Li, Zhizhong Pan, Xiaoshi Zhang, Peirong Ding · 发表于：European Journal of Cancer · 年份：2022 · DOI：10.1016/j.ejca.2022.07.016 · 被引用次数：43 · 研究领域：Cancer Immunotherapy and Biomarkers、Colorectal and Anal Carcinomas、Genetic factors in colorectal cancer

BACKGROUND: In a portion of patients with DNA mismatch repair-deficient (dMMR)/microsatellite instability-high (MSI-H) rectal cancer, clinical complete response (cCR) could be achieved after anti-programmed cell death protein 1 (anti-PD-1) immunotherapy. However, no data are available concerning the safety of omitting surgery and adopting immunotherapy as a curative-intent treatment for these patients. METHODS: We retrospectively collected a series of patients with dMMR/MSI-H rectal adenocarcinoma who had cCR after receiving anti-PD-1 immunotherapy and adopted immunotherapy as curative-intent treatment from six institutions. Survival outcomes were analysed using the Kaplan-Meier method. RESULTS: Nineteen patients were included with a median age of 48 (range 19-63). One patient was diagnosed with stage I disease, four with stage II disease and fourteen with stage III disease. Sixteen patients received anti-PD-1 immunotherapy as the first line of therapy, and eleven patients were treated with single-agent anti-PD-1 antibodies. The median time from the start of treatment to cCR was 3.8 (range 0.7-6.5) months. During a median follow-up of 17.1 (range 3.1-33.5) months since achieving cCR, no local or distant relapse was observed. Two-year local recurrence-free survival, distant metastasis-free survival, disease free-survival and overall survival for the whole cohort were 100%, 100%, 100% and 100%, respectively. CONCLUSIONS: For patients with dMMR/MSI-H locally advanced rectal canc...